1. Pharmacokineticsin the critically illProfessor Jeffrey LipmanDepartment ofIntensive Care MedicineRoyal Brisbane HospitalUniversity of Queensland 2. Pharmacokineticsin…

1. THE ANTIMICROBIAL ARMSRACEGETTING THE LAUNCH CODES RIGHTProfessor Jeffrey LipmanDepartment ofIntensive Care MedicineRoyal Brisbane HospitalUniversity of Queensland 2.…

1. Influenza Disease & Vaccination: Current Perspective with special reference to IndiaDr. Gaurav Gupta, Practising Pediatrician Member AAP, IAP Charak Clinics, Mohali,…

Slide 1VRE - treatment options for severe infections Dr Nick Brown Addenbrookes Hospital, Cambridge 14 March 2013 Conflict of interest: None Slide 2 Evidence biased medicine…

Slide 11 Optimal Prophylaxis: Case for Fluconazole/ Itraconazole Pranatharthi H. Chandrasekar, MD Wayne State University School of Medicine Karmanos Cancer Institute Slide…

Slide 1Cardiovascular Side Effects of HIV Treatment Jean-Guy Baril, MD Mark Wainberg, Phd Slide 2 The D:A:D Cohort What is D:A:D? –The Data Collection on Adverse events…

Slide 1Preparing for Direct Acting Antivirals (DAAs) in PracticeNew Paradigms in the Management of HCV Sherilyn C. Brinkley, MSN, CRNP Nurse Practitioner/Program Manager…

Slide 1New Paradigms in the management of HIV/HCV co- infected patients Sanjay Bhagani Royal Free Hospital London Slide 2 Slide 3 Mortality of HIV-infected patients in France…

Slide 1 Slide 2 Latest Developments in the Treatment of Invasive Aspergillosis William J. Steinbach, MD Assistant Professor of Pediatrics, Molecular Genetics, and Microbiology…

Slide 1Neurological toxicity of Tri-azole Antifungals DR CAROLINE BAXTER Clinical Research Fellow www.aspergillus.org.uk Slide 2 Tri-azole Antifungals VoriconazolePosaconazole…